Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of ... - Quantisnow

Retrieved on: 2024-11-18 21:49:22

Tags for this article:

Click the tags to see associated articles and topics

Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of ... - Quantisnow. View article details on hiswai:

Excerpt

... peptide that selectively blocks the IL-23 receptor in plaque ... Biotechnology: Biological Products (No Diagnostic Substances). $PTGX.

Article found on: quantisnow.com